维生素D在常见病与高死亡率疾病中的循证综述
本文综述随机对照试验、荟萃分析、系统综述及大型前瞻性试验,评估维生素D在基层常见病及2010年以来十大死因相关疾病中的预防与治疗作用。结果显示补充维生素D对心血管病、高血压、癌症预防及认知改善无明显效果,但可能降低COVID-19严重程度与机械通气风险、减少跌倒风险(中等剂量)、改善抑郁与纤维肌痛疼痛、延缓糖尿病前期进展并辅助改善特应性皮炎。
要点
- 已知心血管病患者补充维生素D不降低卒中或心梗风险
- 中等剂量可能减少跌倒风险,高剂量反而可能增加跌倒风险
- 糖尿病前期补充维生素D可降低进展为2型糖尿病的风险
核心结论
- 前瞻性补充维生素D研究显示其对疾病特异性和患者导向结局影响不一,提示低维生素D水平与疾病之间为相关性而非因果性。
- 未来研究应确定维生素D用于治疗和预防的剂量标准与时机。
研究设计与样本
- 本文为文献综述,检索随机对照试验、荟萃分析、系统综述及大型前瞻性试验,聚焦基层常见病及2010年以来十大死因相关疾病。
主要发现
- 已知心血管疾病患者补充维生素D不降低卒中或心脏病发作风险。
- 补充维生素D对高血压治疗或癌症预防似乎无效。
- 新兴证据显示补充维生素D可降低COVID-19严重程度和机械通气风险。
- 中等水平维生素D可能降低跌倒风险,但较高剂量可能增加跌倒风险。
- 补充维生素D与认知改善似乎无关联。
临床怎么用
- 对已知心血管疾病患者不应期待补充维生素D降低卒中或心梗风险。
- 对糖尿病前期患者可考虑补充维生素D以降低进展为2型糖尿病的风险。
- 使用维生素D预防跌倒时应避免高剂量,因高剂量可能增加跌倒风险。
局限性
- 低维生素D水平与疾病的关联多来自观察性研究,补充试验结果不一,提示相关性而非因果性。
- 未来需进一步研究确定维生素D的剂量标准与使用时机。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Vitamin D is a fat-soluble vitamin available from food and sun exposure. Vitamin D receptors are present in cells throughout the body and cause it to act like a hormone. Observational studies document the association of low vitamin D levels with multiple health conditions. This article reviews the evidence for vitamin D in prevention and treatment in primary care. METHODS: We performed a literature review of randomized controlled trials, meta-analyses, systematic reviews, and large prospective trials looking at the role of vitamin D deficiency in the most common conditions seen in primary care and the top 10 causes of mortality since 2010. RESULTS: Vitamin D supplementation in patients with known cardiovascular disease does not reduce risk of stroke or heart attack. Vitamin D supplementation does not seem to have an effect in the treatment of hypertension or in cancer prevention. There is emerging evidence that supplementation reduces COVID-19 severity and risk of mechanical ventilation. Vitamin D at more moderate levels may reduce the risk of falls, but higher doses may cause increased fall risk. There does not seem to be a link between vitamin D supplementation and improved cognition. Vitamin D supplementation may be helpful in patients with major depression. High dose vitamin D may improve pain in people with fibromyalgia. Supplementing patients with prediabetes reduced the risk of progression to type 2 diabetes mellitus. Vitamin D supplementation in addition to standard emollient treatment helped to reduce symptoms in people with atopic dermatitis. CONCLUSION: Prospective studies of vitamin D supplementation demonstrate variable impact on disease specific and patient-oriented outcomes, suggesting a correlation but not a causal relationship between low vitamin D levels and disease pathogenicity. Future research should determine dosing standards and timing of vitamin D in treatment and prevention.
引用
- Michael W, Couture AD, Swedlund M, et al. An Evidence-Based Review of Vitamin D for Common and High-Mortality Conditions. J Am Board Fam Med. 2022. PMID: 36396409. doi:10.3122/jabfm.2022.220115R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。